Allarity Therapeutics, Inc. (ALLR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.49M | -3.24M | -3.41M | -5.48M | -2.69M | -3.21M | -5.44M | -7.22M | -1.4M | -1.67M | -5.38M | -2.5M |
| Operating CF Margin % | -17972% | -1013.44% | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -67.27% | -1.15% | 37.35% | 24.04% | -91.99% | -91.75% | -1.25% | -189.1% | 56.29% | 31.64% | -21.96% | 40.68% |
| Net Income | -2.75M | -3.37M | -2.81M | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M | -1.72M | -4.45M | -2.38M |
| Depreciation & Amortization | -26K | 8K | 0 | 12K | 11K | 1K | 5K | 1K | 2K | 9K | 9K | 18K |
| Stock-Based Compensation | 160K | 47K | 0 | 0 | 139K | 64K | 17K | 111K | -32K | 0 | 124K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | -432K | 0 | -14K | 97K | 0 | 0 |
| Other Non-Cash Items | 96K | 1.37M | 212K | 247K | 45K | 276K | 9.71M | -2.12M | -399K | -3.53M | 754K | -1.25M |
| Working Capital Changes | -1.97M | -1.29M | -816K | -3.42M | -149K | 3.91M | -3.16M | -3.58M | 2.89M | 3.48M | -1.82M | 1.12M |
| Change in Receivables | -216K | 796K | -53K | -494K | -345K | 882K | -73K | -248K | -516K | 748K | -12K | -739K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -47K | -1.57M | -3K | 259K | 177K | -485K | -3.05M | -3.41M | 2.84M | 2.07M | -1.74M | 1.64M |
| Cash from Investing | -64K | 0 | 0 | 0 | 0 | -298K | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -64K | 0 | 0 | 0 | 0 | -298K | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 256% | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 19.74M | -240K | 2.31M | -2.56M | 11.14M | 4.24M | 4.87M | 26.31M | 1.38M | 522K | 6.45M | 2.87M |
| Debt Issued (Net) | 20M | 0 | 0 | 0 | 0 | 0 | 0 | -1.34M | 1.34M | -1.72M | -350K | -2.3M |
| Equity Issued (Net) | -260K | -240K | 2.31M | -2.56M | 11.14M | 4.24M | 4.87M | 27.65M | 40K | 2.24M | 5.08M | 5.16M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -262K | -484K | -141K | -2.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.65M |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.72M | 0 |
| Net Change in Cash | 15.13M | -2.21M | -906K | -9.9M | 8.17M | 1.07M | -770K | 18.92M | 146K | -1.23M | 979K | 125K |
| Free Cash Flow | -4.56M | -3.25M | -3.41M | -5.48M | -2.69M | -3.5M | -5.44M | -7.22M | -1.4M | -1.67M | -5.38M | -2.5M |
| FCF Margin % | -18228% | -1015.94% | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -69.66% | 7.22% | 37.35% | 24.04% | -91.99% | -109.57% | -1.25% | -189.1% | 56.29% | 32.14% | -21.96% | 40.68% |
| FCF per Share | -0.29 | -0.23 | -0.23 | -0.35 | -0.24 | -0.48 | -3.45 | -14.45 | -7.18 | -0.17 | -1.30 | -4.02 |
| FCF Conversion (FCF/Net Income) | 1.63x | 0.96x | 1.22x | 2.36x | 0.98x | 0.43x | 0.47x | 4.43x | 0.36x | 0.97x | 1.21x | 1.05x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |